Sangamo Therapeutics, Inc (SGMO) Insider Ownership

Historic Insider Ownership Trends

Sangamo Therapeutics's three largest insider shareholders as of March 23, 2026 are Inc. Biogen (TenPercentOwner, 17.65Mn shares), Sandy Macrae (President, Ceo And Director, 1.91Mn shares), Nathalie Dubois-Stringfellow (Svp Chief Development Officer, 678.71K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Inc. Biogen 0 17,652,466 28 Sep, 2023
Sandy Macrae President, Ceo And Director 1,907,656 0 26 Feb, 2026
Nathalie Dubois-Stringfellow Svp Chief Development Officer 678,711 0 26 Feb, 2026
Prathyusha Duraibabu Principal Financial Officer 660,042 0 26 Jan, 2026
Scott B. Willoughby Svp, Chief Legal Officer, Secy 651,406 0 26 Feb, 2026
Nikunj Jain Principal Accounting Officer 237,211 0 26 Feb, 2026
David Mark Mcclung Evp, Chief Operating Officer 212,471 0 28 Nov, 2023
Amy Pooler Vp, Head Of Research 193,923 0 27 Aug, 2024
Gregory D Davis Head Of Research Technology 185,111 0 26 Feb, 2026
Rolf Andrew Ramelmeier Evp, Technical Operations 171,467 0 30 May, 2023
Jason D. Fontenot Svp, Chief Scientific Officer 136,270 0 28 Nov, 2023
H Stewart Parker 112,600 0 16 Jun, 2025
Karen L. Smith 102,100 0 16 Jun, 2025
Kenneth J. Hillan 99,600 0 16 Jun, 2025
James R Meyers 99,600 0 16 Jun, 2025
Robert Carey 99,600 0 16 Jun, 2025
John Markels 96,384 0 16 Jun, 2025
Margaret A Horn 82,650 0 16 Jun, 2025
Margaret A Horn 82,650 0 16 Jun, 2025
Courtney Beers 82,650 0 16 Jun, 2025
Robert J. Schott Svp, Head Of Development 75,537 0 01 Mar, 2022
Joseph S Zakrzewski 60,700 0 01 Mar, 2022
Saira Ramasastry 35,700 0 01 Mar, 2022

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
24 Feb, 2026 Sandy Macrae Common Stock D 5,291 $0.47 1,941,293 D F
24 Feb, 2026 Gregory D Davis Common Stock D 832 $0.47 190,230 D F
24 Feb, 2026 Nikunj Jain Common Stock D 666 $0.47 242,330 D F
24 Feb, 2026 Nathalie Dubois-Stringfellow Common Stock D 2,063 $0.47 691,065 D F
24 Feb, 2026 Scott B. Willoughby Common Stock D 1,650 $0.47 663,760 D F
25 Feb, 2026 Nikunj Jain Common Stock D 5,119 $0.47 237,211 D F
25 Feb, 2026 Gregory D Davis Common Stock D 5,119 $0.47 185,111 D F
25 Feb, 2026 Nathalie Dubois-Stringfellow Common Stock D 12,354 $0.47 678,711 D F
25 Feb, 2026 Sandy Macrae Common Stock D 33,637 $0.47 1,907,656 D F
25 Feb, 2026 Scott B. Willoughby Common Stock D 12,354 $0.47 651,406 D F
22 Jan, 2026 Prathyusha Duraibabu Common Stock D 36,676 $0.40 660,042 D F
22 Jan, 2026 Scott B. Willoughby Common Stock D 36,676 $0.40 665,410 D F
22 Jan, 2026 Gregory D Davis Common Stock D 7,721 $0.40 191,062 D F
22 Jan, 2026 Nikunj Jain Common Stock D 7,721 $0.40 242,996 D F
22 Jan, 2026 Sandy Macrae Common Stock D 102,950 $0.40 1,946,584 D F
22 Jan, 2026 Nathalie Dubois-Stringfellow Common Stock D 36,676 $0.40 693,128 D F
24 Nov, 2025 Nathalie Dubois-Stringfellow Common Stock D 2,544 $0.42 719,804 D F
24 Nov, 2025 Sandy Macrae Common Stock D 7,488 $0.42 2,049,534 D F
24 Nov, 2025 Scott B. Willoughby Common Stock D 2,035 $0.42 702,086 D F
24 Nov, 2025 Prathyusha Duraibabu Common Stock D 2,544 $0.42 696,718 D F